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Astrocytes  modulate  synaptic  transmission  via  release  of  gliotransmitters  such  as  ATP, glutamate,  d-
serine  and  l-lactate.  One  of  the  main  problems  when  studying  the  role  of  astrocytes  in vitro and  in  vivo
is  the lack  of suitable  tools  for their  selective  activation.  Optogenetic  actuators  can  be  used to  manip-
ulate  astrocytic  activity  by expression  of  variants  of channelrhodopsin-2  (ChR2)  or  other  optogenetic
actuators  with  the  aim  to  initiate  intracellular  events  such  as intracellular  Ca2+ ([Ca2+]i) and/or  cAMP
increases.  We have  developed  an array  of  adenoviral  vectors  (AVV)  with  ChR2-like  actuators,  including
an  enhanced  ChR2  mutant  (H134R),  and a mutant  with improved  Ca2+ permeability  (Ca2+ translocating
channelrhodopsin,  CatCh).  We  show  here  that  [Ca2+]i elevations  evoked  by ChR2(H134R)  and  CatCh  in
astrocytes  are largely  due  to release  of  Ca2+ from  the intracellular  stores.  The  autocrine  action  of  ATP which
is released  under  these  conditions  and  acts on the  P2Y  receptors  also  contributes  to  the  [Ca2+]i elevations.
We  also studied  effects  evoked  using  light-sensitive  G-protein  coupled  receptors  (opto-adrenoceptors).
Activation  of  opto1AR  (Gq-coupled)  and  opto2AR  (Gs-coupled)  resulted  in  astrocytic  [Ca2+]i increases
which  were  suppressed  by blocking  the corresponding  intracellular  signalling  cascade  (phospholipase
2+C  and  adenylate  cyclase,  respectively).  Interestingly,  the  bulk  of  [Ca ]i responses  evoked  using either
optoAR  was blocked  by  an  ATP  degrading  enzyme,  apyrase,  or  a P2Y1  receptor  blocker,  MRS  2179,
indicating  that  they  are to a large  extent  triggered  by  the  autocrine  action  of  ATP.  We  conclude  that,
whilst  optimal  tools  for control  of  astrocytes  are  yet  to be generated,  the  currently  available  optogenetic
actuators  successfully  initiate  biologically  relevant  signalling  events  in astrocytes.
©  2014  The  Authors.  Published  by Elsevier  Ltd. This  is an open  access  article  under  the  CC BY  license. Introduction
There is a consensus that astrocytes play a major role in the
hysiology of the brain and are actively processing information
ather than passively witnessing the working of neurones. For
ecades the major obstacle for studies into the roles of astro-
ytes was the lack of tools suitable for selective manipulation of
hese cells, in situ, in the context of intact brain tissue. Various
enetic tools targeted to astrocytes have allowed a change in the
ituation. Optogenetic actuators were initially introduced into neu-
oscience with the aim of controlling neuronal activity, but it also
urned out to be possible to manipulate astrocytes by expression
f channelrhodopsin-2 (ChR2) or closely related proteins [1,2].
∗ Corresponding authors.
E-mail addresses: anja.teschemacher@bristol.ac.uk (A.G. Teschemacher),
ergey.kasparov@bristol.ac.uk (S. Kasparov).
ttp://dx.doi.org/10.1016/j.ceca.2014.07.007
143-4160/© 2014 The Authors. Published by Elsevier Ltd. This is an open access article u(http://creativecommons.org/licenses/by/3.0/).
Light-gated ion channels are introduced into neurones in order
to control their membrane potential by light, because these pro-
teins permit cations to cross the plasma membrane leading to
depolarization. In the simplest scenario this allows triggering of
action potentials by ﬂashes of blue light [3]. However, in the
case of astrocytes, such rapid oscillations of membrane potential
appear meaningless as they do not emulate any known physio-
logical mechanism of astrocytic activation. Communication to and
between astrocytes is largely mediated by an array of G-protein-
coupled receptors (GPCRs). Yet, light sensitive ion channels may
still be used to initiate intracellular events reminiscent of the
metabolic activation of astrocytes (for example, release of Ca2+ from
intracellular stores or increase in cAMP or glycogenolysis) or to trig-
ger the release of signalling molecules from astrocytes, such as ATP
[4], glutamate [2,5–7] or l-lactate [8]. How exactly ChR2 leads to
Ca2+ increases in astrocytes is not clear. Usually, it was  assumed
that Ca2+ ions enter the cytosol of the cell from the extracellu-
lar space because ChR2 has low, but detectable, Ca2+ permeability
nder the CC BY license (http://creativecommons.org/licenses/by/3.0/).
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9,10]. We  have generated an array of viral vectors with variants
f ChR2 and re-evaluated this issue using both the enhanced ChR2
utant (H134R) [11] and a more recent mutant with enhanced Ca2+
ermeability termed Ca2+ translocating channelrhodopsin (CatCh)
12]. Speciﬁcally, we have tested whether Ca2+ elevations evoked
y ChR2(H134R) in astrocytes involve release of Ca2+ from intracel-
ular stores and whether autocrine action of ATP, which is secreted
nder these conditions, plays a role. Indeed, it is plausible that ATP
eleased by light stimulation [13] acts on purinergic receptors that
re highly expressed in astrocytes.
Since GPCR activation is more in line with the normal
hysiological functioning of astrocytes, light-sensitive GPCRs
opto-adrenoceptors; optoARs), generated by fusing components
f rhodopsin and either 1- or 2-adrenergic receptors are, per-
aps, a more suitable alternative for astrocyte optogenetics [14].
hese chimaeras were designed to couple to the same intracellular
athways as the native 1- and 2-adrenergic receptors, which in
heory should permit selective activation by light of either Gq- or
s-coupled cascades in astrocytes. In this study, we investigated the
ffects evoked in cultured astrocytes by these tools and compared
hem to those of ChR2 variants.
. Materials and methods
.1. Primary cultures of rat astrocytes
Primary cultures of astrocytes were prepared from the cerebral
ortices, cerebellum and brainstem of Wistar rat pups (P2) follow-
ng protocols adapted from [15] as described previously [13].
Brieﬂy, the brains of Wistar P2 pups were dissected out, crudely
ross-chopped and bathed in a solution containing Hank’s Balanced
alt Solution (HBSS; Invitrogen), deoxyribonuclease I from bovine
ancreas (0.04 mg/ml  of DNase I; Sigma), trypsin from bovine pan-
reas (0.25 mg/ml; Sigma) and bovine serum albumin (3 mg/ml
f BSA; Sigma). The preparation was agitated at 37 ◦C for 15 min.
rypsination of the brain tissue was terminated by the addition of
qual volumes of culture media comprised of Dulbecco’s Modiﬁed
agle Medium (DMEM; Invitrogen), 10% heat-inactivated Foetal
ovine Serum (FBS; Invitrogen), 100 U/ml penicillin and 0.1 mg/ml
treptomycin (P/S; Invitrogen), and then centrifuged at 2000 rpm,
t room temperature for 10 min. The supernatant was  aspirated
ff and the remaining pellet was resuspended twice with a 15 ml
nd 5 ml  solution containing HBSS, BSA (3 mg/ml) and DNase I
0.04 mg/ml). After the cell debris had settled, the cell suspen-
ion was ﬁltered (40 m cell strainer, BD Falcon) and centrifuged
2000 rpm, 5 min, 20 ◦C). Cells were seeded in a T75 ﬂask (Corn-
ng) containing culture media and maintained at 37 ◦C with 5%
O2. Once the cultures reached conﬂuence, the ﬂasks were mildly
haken overnight and media were exchanged to remove microglia
nd oligodendrocytes.
.2. Construction of optogenetic actuator vectors
In this study, we compared the impact on astrocytic [Ca2+]i
andling of four light-sensitive ion channel constructs and
wo light-activated GPCRs: ChR2-Venus, a channelrhodopsin-2
usion with the yellow ﬂuorescent protein Venus; ChR2(H134R)-
atushka1.3, an enhanced channelrhodopsin-2 mutant fused
o the far red-shifted ﬂuorescent protein Katushka1.3 [4,11];
hR2(H134R)-mKate, a fusion with a monomeric version
f Katushka [16]; CatCh-EYFP, a hChR2(L132C) mutant of
hannelrhodopsin-2 with increased Ca2+ permeability fused
o enhanced yellow ﬂuorescent protein [12]; opto1AR-YFP and
pto2AR-YFP, chimaeras of opsin-1- and opsin-2-adrenergic
eceptors, respectively, fused to yellow ﬂuorescent protein [8,14].um 56 (2014) 208–214 209
CatCh was  constructed by mutagenesis from hChR2(H134R)
using the InFusion 2 PCR-cloning kit (Clontech Laboratories,
Mountainview, CA) with the following primers:
VectorFwd-TCACTTGTCCTGTCATCTGTATCCACCTGAGC
VectorBwd-TAACATTGATCCTCAGGGACCAGGACGG
InsertFwd-TGAGGATCAATGTTACTGTGCCGGATGG
InsertBwd-TGACAGGACAAGTGAGCAGCCACTCTGC
Primers generated the L132C mutation (and reverted to R134H)
when used with the template pcDNA3.1v5his-hChR2(H134R)-EYFP
which was kindly provided by Prof. Karl Deisseroth (Stanford Uni-
versity, Stanford, CA). Opto1AR-YFP and opto2AR-YFP clones
were also kindly provided by K. Deisseroth. All constructs were
subcloned into adenoviral shuttle plasmids (pXCX) containing a
shortened promoter of the human glial ﬁbrillary acidic protein
(GfaABC1D; 694-bp) [17]. A two-step transcriptional ampliﬁcation
strategy (TAS) was  used to enhance transgene expression driven by
GfaABC1D [18,19]. This promoter is abbreviated as sGFAP within
the transgene constructs. Adenoviral vectors (AVV) were produced
by spontaneous recombination of the shuttle plasmids and the
helper plasmid (pBHG10), as previously described [20].
Optogenetic constructs are typically expressed in target cells
using strong promoters and multiple copies of viral genomes to
achieve high level of expression. We estimated the potential tox-
icity of overexpression of these biologically active proteins by
comparing cultured astrocytes, transduced with optogenetic and
control (enhanced green ﬂuorescent protein - EGFP) AVV, at a range
of titres (106–1010 TU/ml) for signs of deterioration (i.e., swollen
cells, multinuclear cellular agglomerates and large areas with no
cells present). Transduced astrocytes were daily inspected for signs
of deterioration which, if present, were usually evident already
after 24 h. All ChR2-derived constructs and EGFP-only expressing
AVV caused no visible change in the density or overall appearance of
astrocytes when used in titres 106 TU/ml or 107 TU/ml. Viral vectors
driving the expression of opto1AR and opto2AR did not evoke
any visible detrimental effects when used in titres up to 108 TU/ml.
Higher titres of all AVV, including the EGFP control, had similar
negative effects on morphology and density of astrocytes (Supple-
mentary Fig. S1).
Supplementary material related to this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.ceca.2014.07.007.
2.3. Optogenetic stimulation and [Ca2+]i imaging in cultured
astrocytes
All optogenetic constructs used here are optimally activated by
blue light and have low sensitivity to yellow light. In order to avoid
optogenetic stimulation during [Ca2+]i imaging, we used the Ca2+
indicator Rhod-2 AM (Biotium) which can be excited by the green
or yellow laser of the confocal microscope. Primary cultures of rat
astrocytes seeded onto 13 mm coverslips and transduced with AVV
were loaded with Rhod-2 AM 1 h prior to experimentation. Confo-
cal imaging was carried out at 34 ◦C under continuous superfusion
with HBSS (pH 7.4) in a chamber mounted on an SP2 Leica confo-
cal microscope. Images were acquired through a water immersion
objective (40×)  using the 561 nm laser set to low power (<20%
of the line power) in a time-lapse mode to excite Rhod-2. We
conﬁrmed that this excitation regime was unable to activate the
optogenetic constructs during the very brief scans. Activation of
optogenetic constructs was  achieved with moderate intensity blue
light (470 nm laser diode microscope illumination system from
Rapp OptoElectronic, Germany). In order to illuminate the cells
with blue light and at the same time continue imaging Rhod-2,
we modiﬁed the light path of the confocal microscope and added
an additional dichroic mirror [13]. We  aimed to compare effects of
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Fig. 1. Comparison of ChR2 and its mutants as tools to evoke [Ca2+]i elevations in
cultured astrocytes. (A) Averaged normalised traces recorded in response to light
stimulation in astrocytes transduced with different optogenetic actuators: AVV-
sGFAP-ChR2-Venus (red; n = 50); AVV-sGFAP-ChR2(H134R)-Katushka1.3 (green,
n  = 165); AVV-sGFAP-ChR2(H134R)-mKate (purple, n = 79); AVV-sGFAP-CatCh-EYFP
(blue, n = 86). (B) Summary statistics for peak values of light-induced [Ca2+]i eleva-
tions. Student’s paired t-test was carried out against own baseline. Each column10 M. Figueiredo et al. / Cel
ight stimulation and drugs on cultured astrocytes within the same
overslip. At the same time we wanted to avoid repetitive acti-
ations of the same cohort of cells in order to minimise a possible
mpact of desensitisation or depletion of intracellular Ca2+ stores.
ence, after each stimulation episode the objective was moved to
 new ﬁeld of view in a different part of the coverslip.
.4. Drugs
Drugs were purchased from either Sigma (apyrase, thapsigar-
in, cyclopiazonic acid – CPA) or Tocris Bioscience (MRS 2179,
Q22536 and U73122). Two approaches were used to investigate
nvolvement of purinergic autoreceptors on astrocytes. MRS 2179
s widely considered to be a selective antagonist of metabotropic
2Y1 receptors, but may  also affect P2X1 and P2X3 receptors [21].
pyrase is an ATP-degrading enzyme which can be used to non-
iscriminately block the actions of extracellular ATP. Apyrase was
pplied for 30 min  before light-stimulation of astrocytes.
.5. Data analysis
[Ca2+]i responses in individual astrocytes were assessed using
eica software and expressed as changes in relative ﬂuorescence
ntensity (F/F0, where F0 is the baseline ﬂuorescence of a cell).
urther statistical analysis was carried out using Excel and/or
raphpad Prism® software. A typical ﬂeld of view contained 10–20
ells. Cells with unstable baseline ﬂuorescence (e.g. signiﬁcant
tochastic changes in ﬂuorescence before application of drugs or
ight stimulation) were excluded from the analysis.
. Results
.1. Comparison of ChR2 and its mutants as tools to trigger
Ca2+]i increases in cultured astrocytes
Astrocytes expressing ChR2-Venus, ChR2(H134R)-Katushka1.3,
hR2(H134R)-mKate and CatCh-EYFP were loaded with Rhod-2 AM
nd stimulated with ﬂashes of blue light (20/20 ms duty cycle) for
0 s. Stimulation with the same intensity of light evoked highly
igniﬁcant [Ca2+]i increases which were of comparable magni-
ude between astrocytes expressing the different ChR2 variants
Fig. 1A and B). Since the absolute amplitude of the [Ca2+]i response
epends on both, the properties of the construct and its level of
xpression in the cell (which is limited by potential toxicity and
lso the ability to deliver the construct to the relevant membranes),
his parameter should not be directly interpreted as a measure of
he “power” of individual actuators. At the same time, the latency of
Ca2+]i responses and their overall dynamics were similar between
ll tested ChR2 variants.
.2. Autocrine action of ATP contributes to the [Ca2+]i increases in
hR2(H134R)- and CatCh-expressing astrocytes
ChR2(H134R) can trigger release of ATP from astrocytes [13]
hich is a potent stimulant of Ca2+ release from stores in these
ells. Application of MRS  2179 (10 M),  a P2Y1 receptor antagonist,
igniﬁcantly reduced the light-induced [Ca2+]i increases in both
hR2(H134R) and CatCh-expressing astrocytes (Fig. 2A), indicating
n autocrine action of ATP.
.3. [Ca2+]i increases in ChR2(H134R)- and CatCh-expressing
strocytes are mainly due to release from intracellular storesIt is generally assumed that [Ca2+]i elevations registered in this
nd previous studies are due to the inﬂux of extracellular Ca2+ ions
ia the plasma membrane of the astrocytes. We  have tested therepresents cellular responses pooled from at least 3 independent experiments.
***p  < 0.01. (For interpretation of the references to colour in this ﬁgure legend, the
reader is referred to the web version of the article.)
alternative hypothesis that activation of ChR2(H134R) and CatCh
triggers the release of Ca2+ from intracellular stores. Thapsigar-
gin (1 M),  a potent inhibitor of the ATP-dependent Ca2+ pump of
endoplasmic reticulum (ER), despite the presence of normal con-
centrations of Ca2+ in the extracellular media, almost completely
blocked [Ca2+]i elevations in astrocytes expressing ChR2(H134R)
(Fig. 2B) and CatCh (Fig. 2C) in response to light stimulation (sum-
mary statistics are shown in Fig. 2A). Thus, with both ChR2(H134R)
and CatCh, the bulk of the Ca2+ rise in the cytoplasm of the stimu-
lated astrocytes is derived from thapsigargin-sensitive intracellular
compartments. Interestingly, application of thapsigargin to astro-
cytes expressing CatCh led to a slow build-up of [Ca2+]i even
in the absence of blue light stimulation (Fig. 2C). This was not
observed in cells expressing ChR2(H134R) (Fig. 2B). CPA (10 M),
an inhibitor of the sacroplasmatic reticulum Ca2+ pump, also
potently suppressed Ca2+ elevations evoked by light stimulation
of ChR2(H134R)-expressing astrocytes (p < 0.001, n = 60, data not
shown).
3.4. Opto˛1AR signals via phospholipase C in astrocytes
Light stimulation of opto1AR-expressing and Rhod-2 AM-
loaded astrocytes generated [Ca2+]i elevations (Fig. 3A). To verify
that opto1AR recruits the expected Gq-protein-mediated intrin-
sic signalling pathway in astrocytes, we  used an antagonist of
phospholipase C (PLC), U73122 (10 M),  which completely and
reversibly abolished light-induced ﬂuorescence increases (Fig. 3B).3.5. Optoˇ2AR signals via adenylate cyclase in astrocytes
In astrocytes transduced with opto2AR which are expected to
couple to Gs proteins, light stimulation, surprisingly, also generated
M. Figueiredo et al. / Cell Calcium 56 (2014) 208–214 211
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Fig. 2. [Ca2+]i elevations triggered by ChR2-derived actuators depend on intracellular Ca2+ mobilisation and autocrine ATP action. (A) Pooled summary data for peak [Ca2+]i
responses to light stimulation in ChR2(H134R)-Katushka1.3 or CatCh-EYFP-expressing astrocytes. In presence of MRS  2179 (MRS; 10 M)  and thapsigargin (Thap; 1 M),
[Ca2+]i elevations were signiﬁcantly reduced as compared to control.***p < 0.0001, Student’s unpaired t-test. (B, C) Pre-treatment with thapsigargin (1 M)  for 10 min  decreased
the  light-induced [Ca2+]i increases in astrocytes expressing ChR2(H134R)-Katushka1.3 and CatCh-EYFP. Averaged traces normalised to their own  baselines. Arrows indicate
epochs used for calculation of values in A. Note slow rise in intracellular Ca2+ in CatCh-expressing cells during application of thapsigargin, this effect was highly reproducible.
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Fig. 3. [Ca2+]i elevations in astrocytes in response to optoAR stimulation are mediated by speciﬁc intracellular second messenger cascades. (A) Average increases in [Ca2+]i in
responding stimulated astrocytes expressing opto1AR and opto2AR. ***p < 0.0001 compared to own baselines, Student’s paired t-test. Pooled data from at least 3 indepen-
dent  experiments in each case. (B) The PLC antagonist U73122 (10 M)  completely and reversible abolished light-induced [Ca2+]i increases in astrocytes expressing opto1AR.
**p  < 0.001, Student’s unpaired t-test. (C) The adenylate cyclase inhibitor SQ22536 (100 M)  completely abolished the light-induced [Ca2+]i increases in astrocytes expressing
opto2AR. ***p < 0.0001, Student’s unpaired t-test. (D) [Ca2+]i elevations in opto2AR-expressing astrocytes were completely blocked by U73122 (10 M).  ***p  < 0.0001,
Student’s unpaired t-test.
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Fig. 4. Autocrine action of ATP is responsible for the bulk of the [Ca2+]i elevations evoked using optoARs. (A, B) Extracellular pre-treatment with the ATP degrading enzyme
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hpyrase  strongly attenuated [Ca2+]i responses triggered by light in opto1AR- and op
voked by light stimulation of opto1AR- and opto2AR-expressing astrocytes. ***
Ca2+]i elevations (Fig. 3A). To verify that opto2AR recruits the Gs-
ignalling cascade we used an adenylate cyclase blocker SQ22536
100 M)  which completely suppressed all responses (Fig. 3C). The
ffect of SQ22536 was reversible. [Ca2+]i elevations induced using
pto2AR stimulation were also completely blocked by the PLC
ntagonist U73122 (10 M)  (Fig. 3D).
.6. Autocrine action of ATP mediates the bulk of [Ca2+]i increases
hen astrocytes are activated using optoARs
In order to investigate whether responses evoked in optoAR-
xpressing astrocytes are driven by the autocrine action of ATP,
e pre-treated cultures with the ATP-degrading enzyme apyrase.
pyrase drastically reduced light-induced [Ca2+]i increases in
strocytes expressing either opto1AR or opto2AR (Fig. 4A and
). Similar results were obtained using MRS  2179 (10 M),  which
igniﬁcantly attenuated [Ca2+]i increases in astrocytes expressing
ither opto1AR or opto2AR by approximately 40% (Fig. 4C and
). Effects of MRS  2179 and apyrase were reversible.
. Discussion
There is a consensus that astrocytes play a major role in the
hysiology of the brain and contribute to information processing
ia modulation of neuronal functions. In order to better understand
he roles which these cells play, we need tools which allow us to
electively control their activity and, ideally, mimic  their physio-
ogical activation. Traditionally, communication between different
ell types in the brain was studied using electrophysiological and
harmacological approaches. These techniques, although useful,
ave many limitations. Electrical stimulation of astrocytes is hardlyR-expressing astrocytes. (C, D) MRS  2179 signiﬁcantly attenuated [Ca2+]i responses
001, Student’s unpaired t-test.
meaningful, while drugs designed to understand the role of an
intracellular pathway are hardly ever cell-speciﬁc.
In order to overcome this problem, previous studies used sophis-
ticated molecular approaches, for example ectopic expression in
astrocytes of the receptor Mrg1 in astrocytes [22,23] or an artiﬁcial
designer GPCR [24].
Our laboratory has previously employed the ChR2 variant
ChR2(H134R) to activate astrocytes located within the central
chemosensitive area, the Retrotrapezoid Nucleus [13]. It was
noticed that, upon activation, ChR2(H134R) triggered [Ca2+]i
increases in astrocytes. Similar observations were also made by sev-
eral other groups [1,7]. However, how exactly activation of ChR2 or
similar actuators leads to this [Ca2+]i increase remained unclear.
It has been suggested that light-induced [Ca2+]i increases may  be
evoked by Ca2+ inﬂux from the extracellular space [4] or Na+ entry
through ChR2, followed by the reverse activity of the Na+/Ca2+
exchanger.
Therefore, one of the aims of this study was to re-evaluate this
issue using both the enhanced ChR2 mutant (H134R) [11] and,
for comparison, a more recently developed mutant with enhanced
Ca2+ permeability, CatCh [12]. It was noticeable that CatCh was
not more potent, in terms of speed or amplitude of responses,
or conferred any other advantage. Using thapsigargin, we  demon-
strate here that Ca2+ elevations evoked by both ChR2(H134R) and
CatCh in astrocytes are largely due to the release of Ca2+ from the
intracellular stores. A recent study from the M. Sur and E. Boy-
den laboratories [1] came to a similar conclusion. Curiously, in
CatCh-transduced astrocytes, even without light stimulation thap-
sigargin caused a progressive slow build up in [Ca2+]i over the
course of several minutes. This phenomenon was highly repro-
ducible and suggests that CatCh may  affect Ca2+ handling even
without being activated. At present we do not know the mechanism
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f this effect, but it might indicate an additional stress on ER by this
rotein.
The signiﬁcant reduction in [Ca2+]i responses in the presence
f MRS  2179 is consistent with the idea that stimulated astrocytes
elease ATP, which then acts in an autocrine/paracrine manner, at
east under in vitro conditions (Fig. 2A). It follows that in tissue
ith high activity of ectonucleotidases, responses to ChR2 could be
reatly reduced due to the faster inactivation of ATP. It is worth to
otice that expression of ATP-degrading enzymes indeed may  be
adically different between mice and rats [25] at least in some parts
f the central nervous system.
Although stimulation of ChR2 with blue light triggers ATP
elease, stimulates l-lactate production and release [8], and evokes
Ca2+]i responses in astrocytes, it does not mimic  any endogenous
echanism of astrocyte activation, this being an obvious issue with
he interpretation of the results. Communication to and between
strocytes is generally thought to be mediated mainly by an array
f GPCRs, although other mechanisms such as coupling via local
on gradients and by gap junctions have recently been discovered
26]. Thus, the second aim of this study was to evaluate optogenetic
ools which control astrocytes by selective recruitment of intrin-
ic signalling cascades. In contrast to ChR2 and CatCh, the GPCR
himaeras tangibly mimic  the events evoked by a neurotransmit-
er such as noradrenaline binding to the native 1AR and 2AR.
herefore, such tools in theory provide a better way to optically
ontrol astrocytes. While it could be expected that activation of
 Gq-coupled receptor should result in an increase in [Ca2+]i, we
ere surprised to see the same when using the opto2AR con-
truct (Fig. 3A). Nevertheless, in both cases blocking the early steps
f the intracellular signalling cascades (PLC in case of opto1AR
nd adenylate cyclase in case of opto2AR) abolished Ca2+ eleva-
ions evoked using these artiﬁcial receptors, conﬁrming that they
o couple to the predicted targets. However, our results suggests
hat the [Ca2+]i increases evoked by using both actuators are, in
act, largely due to the autocrine action of ATP (Fig. 4). The residual
esponse remaining after apyrase and MRS  2179 treatment (aver-
ge increases in F/F0 by ∼20%) was too small to further reliably
tudy, but could represent the “pure” effect of opto1AR signalling.
n the case of opto2AR, it is possible that the initial cAMP mediated
tep then leads to cross-activation of PLC via a previously estab-
ished link mediated by exchange protein activated by cAMP (EPAC)
27–30].
Of note, repeated stimulation produced highly variable
esponses in the same astrocytes and for this reason, the effects of
rugs were evaluated on cells only exposed to light once and there-
ore imaged in distinct areas of the same coverslip. A recent study
ound that cAMP responses induced by opto2AR are strongly
ffected by photobleaching which these constructs have inherited
rom their progenitor protein, rhodopsin. By replacing mammalian
psin sequences with those derived from an invertebrate jelly-
sh Carybdea rastonii,  a substantial increase in the performance
f the construct (JellyOp) was achieved [31]. We  would anticipate
hat this new tool will offer signiﬁcant advantages for control of
AMP mediated signalling in astrocytes. Interestingly, we  hardly
ver observed any visible ﬂuorescence in cells transduced with
ptoARs even though both are tagged with YFP. We  speculate that
here may  be a mechanism which caps the expression level of
PCRs in the transduced cells, possibly via targeted degradation.
his feature complicates the use of these constructs in imaging
xperiments because the expressing cells cannot be identiﬁed in
eal time.
Finally, our comparison of the survival rates of cultured astro-
ytes indicated that all AVV driving the expression of ChR2,
hR2(H134R), CatCh and EGFP (the latter known as fairly biologi-
ally inert) caused major cell damage and toxicity at titres in excess
f 108 TU/ml (Supplementary Fig. S1), suggesting that the damageum 56 (2014) 208–214 213
is related to an excessive AVV load rather than a speciﬁc feature of
any of the heterologously expressed proteins.
5. Conclusions
Comparison of various optogenetic actuators in this study has
revealed that all of them share a common signalling effect in astro-
cytes, culminating in release of their main signalling molecule, ATP.
Autocrine action of ATP plays a major role in the [Ca2+]i elevations
induced with both light-sensitive ion channels and optoARs. In
terms of the ability to induce [Ca2+]i responses we  did not detect any
radical differences between ChR2, ChR2(H134R), CatCh or optoARs.
Surprisingly, [Ca2+]i elevations induced by ChR2(H134R) and CatCh
depend almost entirely on Ca2+ release from thapsigargin-sensitive
intracellular stores, possibly due to the retention of these proteins
in the endomembranes. Thus, in terms of end point effects (release
of ATP and l-lactate [8]), ChR2 derivatives are similar to optoARs.
While they are more user friendly, the downside of the use of these
ion channels are the inevitable membrane depolarisations they
evoke which might be seen as non-physiological in astrocytes. We
conclude that the currently available optogenetic constructs can
be employed to initiate robust signalling events in astrocytes but,
clearly, optimal tools for optical control of astrocytic activity are
yet to be generated.
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